Electromed [ELMD] vs Sight Sciences [SGHT] Detailed Stock Comparison

Electromed Inc.

NYSE
Loading...

Sight Sciences Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Electromed Inc. wins in 15 metrics, Sight Sciences Inc. wins in 3 metrics, with 0 ties. Electromed Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Electromed Inc. Sight Sciences Inc. Better
P/E Ratio (TTM) 24.42 N/A N/A
Price-to-Book Ratio 4.58 3.66 Sight Sciences Inc.
Debt-to-Equity Ratio 0.21 63.77 Electromed Inc.
PEG Ratio 0.56 -7.85 Electromed Inc.
EV/EBITDA 15.10 -5.39 Electromed Inc.
Profit Margin (TTM) 13.06% -49.67% Electromed Inc.
Operating Margin (TTM) 19.16% -18.00% Electromed Inc.
EBITDA Margin (TTM) 19.16% N/A N/A
Return on Equity 20.20% -50.74% Electromed Inc.
Return on Assets (TTM) 13.62% -16.61% Electromed Inc.
Free Cash Flow (TTM) $11.09M $-29.92M Electromed Inc.
1-Year Return 86.73% 31.71% Electromed Inc.
Price-to-Sales Ratio (TTM) 3.05 3.07 Electromed Inc.
Enterprise Value $194.43M $182.12M Electromed Inc.
EV/Revenue Ratio 2.82 2.35 Sight Sciences Inc.
Gross Profit Margin (TTM) 78.42% 87.26% Sight Sciences Inc.
Revenue per Share (TTM) $8 $1 Electromed Inc.
Earnings per Share (Diluted) $1.03 $-0.74 Electromed Inc.
Beta (Stock Volatility) 0.32 2.49 Electromed Inc.
Short % of Float 2.47% 2.70% Electromed Inc.

Electromed Inc. vs Sight Sciences Inc. Stock Performance Analysis

Loading Price Chart...

ELMD
SGHT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Electromed Inc.-2.26%-4.49%43.11%51.78%34.34%33.55%
Sight Sciences Inc.0.00%-13.03%2.84%-22.78%-47.71%-41.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Electromed Inc.86.73%219.39%244.79%743.85%1,009.41%847.74%
Sight Sciences Inc.31.71%-35.37%-85.14%-85.14%-85.14%-85.14%

Performance & Financial Health Analysis: Electromed Inc. vs Sight Sciences Inc.

MetricELMDSGHT
Market Information
Market Cap i$212.52M$237.20M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i30,754460,065
90 Day Avg. Volume i43,435341,585
Last Close$35.76$4.34
52 Week Range$17.73 - $40.00$3.11 - $9.24
% from 52W High-10.61%-53.01%
All-Time High$40.00 (May 29, 2026)$42.57 (Aug 02, 2021)
% from All-Time High-10.60%-89.81%
Growth Metrics
Quarterly Revenue Growth0.16%0.07%
Quarterly Earnings Growth0.40%0.07%
Financial Health
Profit Margin (TTM) i0.13%-0.50%
Operating Margin (TTM) i0.19%-0.18%
Return on Equity (TTM) i0.20%-0.51%
Debt to Equity (MRQ) i0.2163.77
Cash & Liquidity
Book Value per Share (MRQ)$5.49$1.20
Cash per Share (MRQ)$1.67$1.70
Operating Cash Flow (TTM) i$9.13M$-29,694,000
Levered Free Cash Flow (TTM) i$7.08M$-16,124,625
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Electromed Inc. vs Sight Sciences Inc.

MetricELMD (Apr 24, 2026)SGHT (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i24.42N/A
Forward P/E i41.23-7.85
PEG Ratio i0.56-7.85
Price to Sales (TTM) i3.053.07
Price to Book (MRQ) i4.583.66
Market Capitalization
Market Capitalization i$212.52M$237.20M
Enterprise Value i$194.43M$182.12M
Enterprise Value Metrics
Enterprise to Revenue i2.822.35
Enterprise to EBITDA i15.10-5.39
Risk & Other Metrics
Beta i0.322.49
Book Value per Share (MRQ) i$5.49$1.20

Financial Statements Comparison: Electromed Inc. vs Sight Sciences Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricELMD (2025)SGHT (2025)
Revenue/Sales i64.00M77.36M
Cost of Goods Sold i14.03M10.70M
COGS % of Revenue i21.9%13.8%
Gross Profit i49.97M66.67M
Gross Margin i78.1%86.2%
Research & Development i996,00014.61M
Operating Income (EBIT) i9.66M-37.10M
Operating Margin i15.1%-48.0%
EBITDA i10.83M-36.76M
EBITDA Margin i16.9%-47.5%
Pre-Tax Income i10.28M-38.42M
Pre-Tax Income % of Revenue i16.1%-49.7%
Income Tax i2.75M10,000
Income Tax % of Revenue i4.3%0.0%
Net Income (Profit) i7.54M-38.43M
Profit Margin i11.8%-49.7%

Balance Sheet & Liquidity Metrics

MetricELMD (2025)SGHT (2025)
Cash & Equivalents i15.29M91.97M
Total Current Assets i45.08M112.73M
Total Current Assets % of Revenue i70.4%145.7%
Total Current Liabilities i10.47M11.03M
Total Current Liabilities % of Revenue i16.4%14.3%
Long-Term Debt iN/A40.30M
Long-Term Debt % of Revenue i0.0%52.1%
Total Shareholders Equity i43.21M63.94M
Retained Earnings i21.19M-384.72M
Retained Earnings % of Revenue i33.1%-497.3%
Property, Plant & Equipment i4.63M2.65M

Cash Flow Statement Comparison

MetricELMD (2025)SGHT (2025)
Operating Cash Flow i11.64M-24.47M
Operating Cash Flow % of Revenue i18.2%-31.6%
Capital Expenditures iN/A-224,000
Free Cash Flow i11.09M-29.92M
FCF Margin i17.3%-38.7%
Debt Repayment iN/A0
Common Stock Repurchase i-10.00MN/A

Short Interest & Institutional Ownership Analysis

MetricELMDSGHT
Shares Short i190,4331.07M
Short Ratio i3.792.42
Short % of Float i2.47%2.70%
Shares Outstanding i8.28M53.49M
Float Shares i6.49M35.29M
% Held by Insiders i21.45%20.96%
% Held by Institutions i59.90%48.49%
% Held by Public i18.65%30.55%

Dividend Analysis & Yield Comparison: Electromed Inc. vs Sight Sciences Inc.

MetricELMDSGHT
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A